Skip to main content
Premium Trial:

Request an Annual Quote

Incyte Licenses LifeSeq Gold to Two Japanese Pharmas

NEW YORK, Dec 4 – Incyte said Monday it had licensed LifeSeq gold and its ZooSeq animal model database to Sumitomo Pharmaceuticals and Sankyo of Tokyo, Japan.

Researchers at both companies will become the first Incyte customers to access LifeSeq through Incyte’s website, Incyte.com. Incyte.com uses encryption technologies that are used in online commercial transactions to protect the security of data queries and other information.

Financial terms of the agreements were not disclosed.

" We are pleased to continue our penetration of the Japanese market," Incyte CEO Roy Whitfield said in a statement referring to the Sumitomo deal.

Sankyo is Japan’s second-largest pharmaceutical company. Sumitomo Pharmaceuticals, a subsidiary of the $103 billion trading giant Sumitomo, was recently spun off from Sumitomo Chemicals.

This is the second collaboration a Sumitomo subsidiary has formed with a Western genomic information company in the last month. In November, Viaken announced it had signed an agreement with SC Biosciences to jointly explore marketing opportunities in Japan for its bioinformatics hosting platforms.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.